CGON250516C7500
- 0.00
- 0.000.00%
CG Oncology Newsroom
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
J.P. Morgan Initiates CG Oncology(CGON.US) With Buy Rating, Announces Target Price $41
Analysts' Opinions Are Mixed on These NA Stocks: Reddit Inc Class A (RDDT) and CG Oncology, Inc. (CGON)
Express News | CG Oncology Inc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $41
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $68
BofA Securities Initiates CG Oncology(CGON.US) With Buy Rating, Announces Target Price $63
CG Oncology Is Maintained at Outperform by RBC Capital
Buy Rating for CG Oncology, Inc. Driven by Cretostimogene's Potential in Bladder Cancer Treatment Amid BCG Shortage
RBC Raises Price Target on CG Oncology to $68 From $66, Keeps Outperform, Speculative Risk
CG Oncology Stock (CGON) Surges 25% As Cancer Drug Shows Remarkable Results
Top Midday Gainers
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
$CGON Stock Is up 31% Today. Here's What We See in Our Data.
CG Oncology Price Target Maintained With a $75.00/Share by Cantor Fitzgerald
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
CG Oncology Shares Climb on Bladder-Cancer Treatment Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
CG Oncology Announces Promising Phase 3 Trial Results